Solid Biosciences Inc. (SLDB)
Last updated: 2026-10-20 17:52:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Solid Biosciences Inc. (SLDB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.47, with a market capitalization of $592.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.79 to $11.45. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$592.96M | |
$5.83 | |
$822.60 | |
$1.81 | |
$5.92 | |
845.48K | |
1.16M | |
-- | |
$11.45 | |
$3.79 | |
-- | |
-- |
Solid Biosciences Inc. (SLDB) Stock Price Today
Solid Biosciences Inc. (SLDB) is currently trading at $6.47 as of 2026-10-20 17:51:00, up 9.21% ($0.54) from the previous close of $5.92
During today's regular trading session, SLDB has traded between $1.81 and $822.60, with a trading volume of 845.48K shares. The current price is near the lower end of today's range.
Solid Biosciences Inc. (SLDB) 7-Day Stock Price Change
Over the past seven days, Solid Biosciences Inc. (SLDB) moved from $6.87 to $6.47, representing a decline of 5.90% ($0.41).
The stock traded between $5.39 and $7.05 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 1.69 million shares, up versus the previous seven-day period, indicating higher trading activity.
SLDB 52-Week Price Position
Position in Range: 34.9%
SLDB is currently trading at $6.47, placing it 34.9% of the way from its 52-week low of $3.79 to its 52-week high of $11.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Solid Biosciences Inc. (SLDB)?
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Solid Biosciences Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 121 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Solid Biosciences Inc. (SLDB) Stock on MEXC
Eligible investors can buy real shares of Solid Biosciences Inc. (SLDB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Solid Biosciences Inc. (SLDB) stock price today?
2.Is SLDB stock going up or down today?
3.What is SLDB pre-market price?
4.What is SLDB after-hours price?
5.Is SLDB stock trading now?
6.Where does SLDB sit relative to its 52-week high and low?
7.What sector is Solid Biosciences Inc. in?
8.What is Solid Biosciences Inc.'s market capitalization and where is it listed?
9.How is SLDB valued in terms of P/E ratio and EPS?
10.Does Solid Biosciences Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SLDB Stock Calculator
Estimate the value between SLDB shares and USD.
SLDB Shares to USD
1.00 SLDB shares = 6.465 USD
Calculations are estimates based on the latest available price and are for reference only.


